L-ornithine L-aspartate (LOLA) - Hepatic encephalopathy
You are here : Home > Formulary Search > L-ornithine L-aspartate (LOLA) - Hepatic encephalopathy
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Documentation
- No records returned.
PAD Profile
ChemicalSubstance :
L-ornithine L-aspartate (LOLA)
Indication :
Hepatic encephalopathy
Group Name :
Keywords :
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Other Indications
Below are listed other indications that L-ornithine L-aspartate (LOLA) is used to treat.
- No records returned.
Other Drugs
Below are listed other drugs that are used to treat Hepatic encephalopathy.
Committee Recommendations (1)
This drug has been included on the joint formulary having been agreed by the DTC of at least one Surrey Heartlands Acute Trust.
See “Formulary Status” to identify where this drug has been agreed for use.